Financial Performance - Q2 FY25 - Enerpac Tool Group's net sales reached $146 million, reflecting a 5.1% increase compared to Q2 FY24[5] - Organic sales growth for Enerpac Tool Group was 50%[5] - Adjusted EBITDA was $34 million, with an adjusted EBITDA margin of 232%[11] - Adjusted EPS stood at $039, an 8% increase year-over-year[11] Segment Performance - Q2 FY25 - Industrial Tools & Service (IT&S) net sales were $141 million, a 4% increase from $135 million in Q2 FY24[5] - IT&S Product sales increased by 5% to $114 million[5] - IT&S Service sales increased by 2% to $27 million[5] - Other sales (Cortland Biomedical) increased by 331% to $5 million[5] Liquidity and Capital Allocation - The company maintains strong liquidity with $120 million in cash and equivalents[12] - Undrawn revolver capacity is $399 million, resulting in total liquidity of $518 million[12] - Total debt is $192 million, with a net debt to adjusted EBITDA ratio of 05x[12] FY25 Guidance - The company projects net sales between $610 million and $625 million, with organic growth of approximately 0-2% and total growth of approximately 3-6%[27] - Adjusted EBITDA is expected to be in the range of $150 million to $160 million[27] - Free cash flow is projected to be between $85 million and $95 million[27]